Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,327

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,859

Class I recallsReasonable probability of serious health consequences

24,440

Class II recallsTemporary or medically reversible health consequences

2,900

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,095 recalls

Newest recallhttps://www.fsis.usda.gov/recalls-alerts/imperio-distribution-llc-recalls-beef-jerky-products-produced-without-benefitPublished October 24, 2026

Most affected stateHawaii 200 recalls mention this state

State: GU ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 26, 2026 ET

Summary (Year to date)

1,739 recalls have been announced year to date.
Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (300).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,440
Class I	9,859
Class III	2,900
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,440
Class I	9,859
Class III	2,900
Not Yet Classified	2

FDA Recall TerminatedTerminated: February 6, 2024Historical recordClass II

PEPPERMINT LIP MOISTURIZER (oxybenzone (4%) and Octinoxate (7%) SPF 15, 4.2 g tube, labeled as a) Bimark Inc., bimark.com; b) NOCO TRAIL REPORT, www.NoCoTrailReport.org; c) Herbruck's, d) St. Mark's Outpatient Surgery Center, 1250 East 3900 South Suite 100, Salt Lake City, UT 84124, e) Trust Company Oklahoma, trustok.com, f) Creekside Dental, www.creeksidedentalkennewick.com, g) Children's Healthcare of Atlanta Hughes Spalding, h) Great Smiles Orthodontics, Dr. Savage & Dr. Weissman, Crestline. Inverness.Turssville, www.bracebygreatsmiles.com, i) Acceleration station, j) The Children's Therapy & Learning Center, www.childrenstlc.com. FLAVORED LIP MOISTURIZER (oxybenzone (4%) and Octinoxate (7%) SPF 15, 4.2 g tube labeled as a) Gregory P. Miller DDS FAGD, 1140 South Avenue North Mankato, MN 56003, www.gregmillerdds.com, b) Shelby, c) Carolina Custom Traders, Wake Forest, North Carolina, c) Palm Springs Dental Associates Jonathan W. Preble, DMD, 499 E. Central Parkway, Suite 200, Altamonte Springs, FL 32701, www.drjpreble.com. LIP MOISTURIZER (oxybenzone (4%) and Octinoxate (7%) SPF 15, 4.2 g tube labeled as Family Dental of Thronton, 12889 Quebec St, Thornton, CO 80602, www.FamilyDentalofThornton.com.

by Yusef Manufacturing Laboratories, LLC

Reason: Superpotent drug: This lot of SPF containing lip balm contains up to 150% of the label claim for active ingredient Oxybenzone.
Published: April 29, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2021Historical recordClass II

Lisinopril Tablets USP, 20 mg, 1000-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore MD 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, India. NDC 68180-0981-03

by Lupin Pharmaceuticals Inc.

Reason: Product Mix-Up: a complaint received indicating mix-up of 10 mg Lisinopril tablets inside of 2 sealed bottles of 20 mg/1000 count bottles.
Published: April 29, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 17, 2024Historical recordClass II

Daytrana (methylphenidate transdermal system) Delivers 30 mg over 9 hours (3.3 mg/hr) 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC Miami, FL 33186, NDC 68968-5555-3

by Noven Therapeutics, LLC

Reason: Defective Delivery System: Out of specification for mechanical peel and shear.
Published: April 29, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 17, 2024Historical recordClass II

Daytrana (methylphenidate transdermal system) Delivers 20 mg over 9 hours (2.2 mg/hr) 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC Miami, FL 33186, NDC 68968-5554-3

by Noven Therapeutics, LLC

Reason: Defective Delivery System: Out of specification for mechanical peel and shear.
Published: April 29, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 17, 2024Historical recordClass II

Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr), 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC Miami, FL 33186, NDC 68968-5552-3

by Noven Therapeutics, LLC

Reason: Defective Delivery System: Out of specification for mechanical peel and shear.
Published: April 29, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 24, 2020Historical recordClass II

Estradiol, USP (Non-Micronized) (Hemihydrate), packaged in: a) 500 grams (NDC 63275-9900-8), b) 100 grams (NDC 63275-9900-5), c) 25 grams (NDC 63275-9900-4), Distributed by B&B Pharmaceuticals, Inc. 800-499-3100

by B & B Pharmaceuticals, Inc.

Reason: cGMP deviations: Presence of foreign material (Teflon)introduced at the production level.
Published: April 22, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: January 14, 2022Historical recordClass II

Dermatone (avobenzone, homosalate, octisalate, and octocrylene) Sunscreen Lotion Fragrance Free, SPF 50, packaged in a) 1.5 fl. oz. (44 mL) tottles, UPC: 087052727338; b) 2 Fl. OZ. (59 mL) tubes, UPC: 08705272732; c) 4 FL. OZ. (118 mL) tubes, UPC: 087052727345, Distributed By: Beaumont Products, Inc. Kennesaw, GA 30144

by Filltech USA, LLC

Reason: Microbial contamination of non-sterile products: positive test for yeast and bacteria.
Published: April 22, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: January 14, 2022Historical recordClass II

Dermatone (avobenzone, homosalate, octisalate, and octocrylene) Sunscreen Lotion Fragrance Free, SPF 30, package in 1.5 fl. oz. (44 mL) tottles, Distributed By: Beaumont Products, Inc. Kennesaw, GA 30144, UPC 020908422698

by Filltech USA, LLC

Reason: Microbial contamination of non-sterile products: positive test for yeast and bacteria.
Published: April 22, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 25, 2024Historical recordClass II

Oxycodone and Acetaminophen Tablets, USP 10 mg*/325 mg 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 13107-046-01

by Aurobindo Pharma USA Inc.

Reason: CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Published: April 22, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 25, 2024Historical recordClass II

Phentermine Hydrochloride Capsules, USP 15mg, 100-count bottles, Distributed by: Aurobindo Phama USA, Inc. Dayton, NJ 08810, NDC 13107-105-01

by Aurobindo Pharma USA Inc.

Reason: CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Published: April 22, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 25, 2024Historical recordClass II

Mirtazapine Tablets, USP 15mg, 30-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 13107-031-34

by Aurobindo Pharma USA Inc.

Reason: CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Published: April 22, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 25, 2024Historical recordClass II

Simvastatin Tablets, USP 40mg 90-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65862-053-90

by Aurobindo Pharma USA Inc.

Reason: CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Published: April 22, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 25, 2024Historical recordClass II

Levetiracetam Tablets USP 750 mg 120-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, NDC 65862-247-08

by Aurobindo Pharma USA Inc.

Reason: CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Published: April 22, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 25, 2024Historical recordClass II

Acetaminophen and Codeine Phosphate Tablets, USP, 300 mg/60 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ 08810, NDC 13107-060-01

by Aurobindo Pharma USA Inc.

Reason: CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Published: April 22, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 25, 2024Historical recordClass II

Acetaminophen and Codeine Phosphate Tablets, USP, 300 mg/30 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ 08810, NDC 13107-059-99

by Aurobindo Pharma USA Inc.

Reason: CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Published: April 22, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 25, 2024Historical recordClass II

Acetaminophen and Codeine Phosphate Tablets, USP, 300 mg/15 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ 08810, NDC 13107-058-01

by Aurobindo Pharma USA Inc.

Reason: CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Published: April 22, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 8, 2020Historical recordClass II

Losartan Potassium Tablets, USP, 25 mg, Rx only, a) 30 ct. (NDC 60429-316-30) b) 90ct. (NDC 60429-316-90) c) 1,000 ct. (60429-316-10) bottles, GSMS Incorporated, Manufactured by Arrow Pharm (Malta) Ltd., Packaged by GSMS Incorporated, Camarillo, CA 93012, USA

by Golden State Medical Supply Inc.

Reason: CGMP Deviations: Impurity for N-nitroso-N-methyl-4-aminobutryric Acid (NBMA) detected in active ingredient (API) used to manufacture finished products.
Published: April 22, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 25, 2024Historical recordClass II

Gabapentin Capsules, USP 100mg 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65862-198-99

by Aurobindo Pharma USA Inc.

Reason: CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Published: April 22, 2020
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: January 6, 2021Historical recordClass I

Mountain Rose Inc. dba Mountain Rose Herbs

Product: Kudzu Root (Pueraria montana var. lobata), This product was…
Reason: Salmonella
Published: April 22, 2020
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 23, 2022Historical recordClass I

Tetracycline HCL Capsules, USP, 250 mg, 100-count Bottle, Rx Only, Manufactured for: Heritage Pharmaceuticals Inc. East Brunswick NJ 08816. NDC 23155-017-01

by Avet Pharmaceuticals, Inc.

Reason: Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules.
Published: April 15, 2020
Distribution: Nationwide

View recall →

Data last updated: October 26, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.